We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CGON market cap is 2.26B. The company's latest EPS is USD -1.0025 and P/E is -33.46.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1,000 | 529k | 111k |
| Operating Income | -18.93M | -22.47M | -25.85M |
| Net Income | -22.05M | -16.93M | -18.9M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10.36M | 191k | 204k |
| Operating Income | -12.61M | -35.25M | -55.45M |
| Net Income | -18.38M | -43.79M | -67.8M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 199.3M | 579.11M | 564.33M |
| Total Liabilities | 14.51M | 10.17M | 11.97M |
| Total Equity | -123.1M | 568.94M | 552.36M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 58.69M | 147.75M | 199.3M |
| Total Liabilities | 18.44M | 22.57M | 14.51M |
| Total Equity | -42.62M | -77.69M | -123.1M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.68M | -26.01M | -42.13M |
| Investing | -121.2M | -307.44M | -343.67M |
| Financing | 87M | 402.66M | 402.7M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.65M | -29.8M | -45.68M |
| Investing | -97k | -55.35M | -121.2M |
| Financing | 15.45M | 119.69M | 87M |
| Market Cap | 2.26B |
| Price to Earnings Ratio | -33.46 |
| Price to Sales Ratio | 11.18k |
| Price to Cash Ratio | 274.47 |
| Price to Book Ratio | 12.28 |
| Dividend Yield | - |
| Shares Outstanding | 67.63M |
| Average Volume (1 week) | 598.52k |
| Average Volume (1 Month) | 432.1k |
| 52 Week Change | 15.41% |
| 52 Week High | 50.23 |
| 52 Week Low | 25.77 |
| Spread (Intraday) | 2.3 (6.43%) |
| Company Name | CG Oncology Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://cgoncology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
